Phase I / II study of brentuximab vedotin in J apanese patients with relapsed or refractory CD 30‐positive H odgkin's lymphoma or systemic anaplastic large‐cell lymphoma

Cancer Science ◽

10.1111/cas.12435 ◽

2014 ◽

Vol 105 (7) ◽

pp. 840-846 ◽

Author(s):

Michinori Ogura ◽

Kensei Tobinai ◽

Kiyohiko Hatake ◽

Kenichi Ishizawa ◽

Naokuni Uike ◽

...

Keyword(s):

Phase I ◽

Anaplastic Large Cell Lymphoma ◽

Cell Lymphoma ◽

Brentuximab Vedotin ◽

Large Cell Lymphoma

Download Full-text

Phase I study of brentuximab vedotin (SGN-35) in Japanese children with relapsed or refractory CD30-positive Hodgkin’s lymphoma or systemic anaplastic large cell lymphoma

10.1055/s-0040-1701850 ◽

2020 ◽

Author(s):

Y Koga ◽

M Sekimizu ◽

A Iguchi ◽

A Kada ◽

A Saito ◽

...

Keyword(s):

Phase I ◽

Anaplastic Large Cell Lymphoma ◽

Phase I Study ◽

Hodgkin’S Lymphoma ◽

Cell Lymphoma ◽

Brentuximab Vedotin ◽

Hodgkin's Lymphoma ◽

Japanese Children ◽

Large Cell Lymphoma

Download Full-text

Phase I clinical study of brentuximab vedotin (SGN-35) involving children with recurrent or refractory CD30-positive Hodgkin’s lymphoma or systemic anaplastic large cell lymphoma: rationale, design and methods of BV-HLALCL study: study protocol

10.1186/s12885-018-4042-1 ◽

2018 ◽

Vol 18 (1) ◽

Author(s):

Masahiro Sekimizu ◽

Akihiro Iguchi ◽

Tetsuya Mori ◽

Yuhki Koga ◽

Akiko Kada ◽

...

Keyword(s):

Clinical Study ◽

Phase I ◽

Study Protocol ◽

Anaplastic Large Cell Lymphoma ◽

Cell Lymphoma ◽

Brentuximab Vedotin ◽

Hodgkin's Lymphoma ◽

Large Cell Lymphoma ◽

Design And Methods

Download Full-text

Phase I study of brentuximab vedotin (SGN-35) in Japanese children with relapsed or refractory CD30-positive Hodgkin’s lymphoma or systemic anaplastic large cell lymphoma

International Journal of Hematology ◽

10.1007/s12185-020-02820-1 ◽

2020 ◽

Vol 111 (5) ◽

pp. 711-718

Author(s):

Yuhki Koga ◽

Masahiro Sekimizu ◽

Akihiro Iguchi ◽

Akiko Kada ◽

Akiko M. Saito ◽

...

Keyword(s):

Phase I ◽

Anaplastic Large Cell Lymphoma ◽

Phase I Study ◽

Hodgkin’S Lymphoma ◽

Cell Lymphoma ◽

Brentuximab Vedotin ◽

Hodgkin's Lymphoma ◽

Japanese Children ◽

Large Cell Lymphoma

Download Full-text

Experience of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma and relapsed/refractory systemic anaplastic large-cell lymphoma in the Named Patient Program: Review of the literature

Critical Reviews in Oncology/Hematology ◽

10.1016/j.critrevonc.2015.03.011 ◽

2015 ◽

Vol 95 (3) ◽

pp. 359-369 ◽

Author(s):

P.L. Zinzani ◽

S. Sasse ◽

J. Radford ◽

O. Shonukan ◽

V. Bonthapally

Keyword(s):

Hodgkin Lymphoma ◽

Anaplastic Large Cell Lymphoma ◽

Cell Lymphoma ◽

Brentuximab Vedotin ◽

Program Review ◽

Review Of The Literature ◽

Large Cell Lymphoma ◽

Refractory Hodgkin Lymphoma

Download Full-text

Phase II single-arm study of brentuximab vedotin in Chinese patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large cell lymphoma

Expert Review of Hematology ◽

10.1080/17474086.2021.1942831 ◽

2021 ◽

Author(s):

Yuqin Song ◽

Ye Guo ◽

Huiqiang Huang ◽

Wei Li ◽

Xiaoyan Ke ◽

...

Keyword(s):

Hodgkin Lymphoma ◽

Phase Ii ◽

Anaplastic Large Cell Lymphoma ◽

Cell Lymphoma ◽

Brentuximab Vedotin ◽

Chinese Patients ◽

Classical Hodgkin Lymphoma ◽

Large Cell Lymphoma

Download Full-text

Faculty Opinions recommendation of Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734167581.793581834 ◽

2021 ◽

Author(s):

David Teachey

Keyword(s):

Anaplastic Large Cell Lymphoma ◽

Hodgkin’S Lymphoma ◽

Cell Lymphoma ◽

Phase 1 ◽

Brentuximab Vedotin ◽

Hodgkin's Lymphoma ◽

Open Label Phase ◽

Large Cell Lymphoma

Download Full-text

Case 19. Successful treatment of primary cutaneous anaplastic large cell lymphoma on the penile shaft with brentuximab vedotin and allogenic stem cell transplant

Cutaneous Lymphomas ◽

10.1007/978-3-030-59129-8_19 ◽

2021 ◽

pp. 42-43

Author(s):

J. Yoo ◽

A. Stevens ◽

S. Chaganti ◽

J. Scarisbrick

Keyword(s):

Stem Cell ◽

Successful Treatment ◽

Anaplastic Large Cell Lymphoma ◽

Cell Lymphoma ◽

Brentuximab Vedotin ◽

Cell Transplant ◽

Penile Shaft ◽

Allogenic Stem Cell Transplant ◽

Large Cell Lymphoma

Download Full-text

Retreatment with brentuximab vedotin in patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large-cell lymphoma: a multicenter retrospective study

Leukemia & Lymphoma ◽

10.1080/10428194.2019.1654100 ◽

2019 ◽

Vol 61 (1) ◽

pp. 176-180 ◽

Author(s):

Noriko Fukuhara ◽

Go Yamamoto ◽

Hideki Tsujimura ◽

Takaaki Chou ◽

Hirohiko Shibayama ◽

...

Keyword(s):

Retrospective Study ◽

Hodgkin Lymphoma ◽

Anaplastic Large Cell Lymphoma ◽

Cell Lymphoma ◽

Brentuximab Vedotin ◽

Classical Hodgkin Lymphoma ◽

Large Cell Lymphoma

Download Full-text

Complete Response of Relapsed Systemic and Cutaneous Anaplastic Large Cell Lymphoma Using Brentuximab Vedotin: 2 Case Reports

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2013.03.008 ◽

2013 ◽

Vol 13 (4) ◽

pp. 493-495 ◽

Author(s):

Alessandro Broccoli ◽

Enrico Derenzini ◽

Cinzia Pellegrini ◽

Riccardo Narducci ◽

Giulia Stefani ◽

...

Keyword(s):

Anaplastic Large Cell Lymphoma ◽

Cell Lymphoma ◽

Case Reports ◽

Complete Response ◽

Brentuximab Vedotin ◽

Large Cell Lymphoma

Download Full-text

Brentuximab vedotin as monotherapy for unresectable breast implant‐associated anaplastic large cell lymphoma

Clinical Case Reports ◽

10.1002/ccr3.2142 ◽

2019 ◽

Vol 7 (5) ◽

pp. 1003-1006 ◽

Author(s):

Anthony Stack ◽

Isaac Levy

Keyword(s):

Anaplastic Large Cell Lymphoma ◽

Cell Lymphoma ◽

Breast Implant ◽

Brentuximab Vedotin ◽

Large Cell Lymphoma

Download Full-text